Evidence map›Paper›PMID 32751604›Full record

ArticlePolymers2020

Micro-Clotting of Platelet-Rich Plasma Upon Loading in Hydrogel Microspheres Leads to Prolonged Protein Release and Slower Microsphere Degradation.

Miran Hannah Choi, Alexandra Blanco, Samuel Stealey, Xin Duan, Natasha Case, Scott Allen Sell, Muhammad Farooq Rai, Silviya Petrova Zustiak

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. [Research progress of hydrogel-based growth factors for treatment of intervertebral disc degeneration].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. Black Phosphorus Tagged Responsive Strontium Hydrogel Particles for Bone Defect Repair.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Microfluidic Chip Device forLangmuir : the ACS journal of surfaces and colloids · 2021
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Miran Hannah ChoiProgram of Biomedical Engineering, School of Engineering, Saint Louis University, Saint Louis, MO 63103, USA.
Alexandra BlancoProgram of Biomedical Engineering, School of Engineering, Saint Louis University, Saint Louis, MO 63103, USA.
Samuel StealeyProgram of Biomedical Engineering, School of Engineering, Saint Louis University, Saint Louis, MO 63103, USA.
Xin DuanDepartment of Orthopedic Surgery, Washington University in St. Louis, School of Medicine, Saint Louis, MO 63110, USA.
Natasha CaseProgram of Biomedical Engineering, School of Engineering, Saint Louis University, Saint Louis, MO 63103, USA.
Scott Allen SellProgram of Biomedical Engineering, School of Engineering, Saint Louis University, Saint Louis, MO 63103, USA.ORCID 0000-0002-6785-3193
Muhammad Farooq RaiDepartment of Orthopedic Surgery, Washington University in St. Louis, School of Medicine, Saint Louis, MO 63110, USA.ORCID 0000-0003-4826-4331
Silviya Petrova ZustiakProgram of Biomedical Engineering, School of Engineering, Saint Louis University, Saint Louis, MO 63103, USA.ORCID 0000-0002-7648-8351
Saint Louis University · USWashington University in St. Louis · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI AIMEE S JAMES · 2001 to 2026
$128.0M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
WU-MDACC Inter-Institutional Molecular Imaging CenterP50CA094056 · NCI · WASHINGTON UNIVERSITY · PI PIWNICA-WORMS, DAVID · 2002 to 2016
$26.3M
NCATS NIH HHS UL1 TR002345NCI NIH HHS P30 CA091842NCI NIH HHS P50 CA094056Washington University Institute of Clinical and Translational Sciences CTRF108
6 · The paper itself

Abstract

Platelet-rich plasma (PRP) is an autologous blood product that contains a variety of growth factors (GFs) that are released upon platelet activation. Despite some therapeutic potential of PRP in vitro, in vivo data are not convincing. Bolus injection of PRP is cleared rapidly from the body diminishing its therapeutic efficacy. This highlights a need for a delivery vehicle for a sustained release of PRP to improve its therapeutic effect. In this study, we used microfluidics to fabricate biodegradable PRP-loaded polyethylene glycol (PEG) microspheres. PRP was incorporated into the microspheres as a lyophilized PRP powder either as is (powder PRP) or first solubilized and pre-clotted to remove clots (liquid PRP). A high PRP loading of 10%

Indexed as

drug deliveryinjectablemicrospherespolyethylene glycolPRP therapy

Identifiers

PMID32751604
PMCPMC7464943
OpenAlexW3046090877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.